Authors:
Boyd, MR
Farina, C
Belfiore, P
Gagliardi, S
Kim, JW
Hayakawa, Y
Beutler, JA
McKee, TC
Bowman, BJ
Bowman, EJ
Citation: Mr. Boyd et al., Discovery of a novel antitumor benzolactone enamide class that selectivelyinhibits mammalian vacuolar-type (H+)-ATPases, J PHARM EXP, 297(1), 2001, pp. 114-120
Authors:
Blaney, FE
Raveglia, LF
Artico, M
Cavagnera, S
Dartois, C
Farina, C
Grugni, M
Gagliardi, S
Luttmann, MA
Martinelli, M
Nadler, GMMG
Parini, C
Petrillo, P
Sarau, HM
Scheideler, MA
Hay, DWP
Giardina, GAM
Citation: Fe. Blaney et al., Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity andselectivity in quinoline tachykinin receptor antagonists, J MED CHEM, 44(11), 2001, pp. 1675-1689
Authors:
Marsano, E
Bianchi, E
Gagliardi, S
Ghioni, F
Citation: E. Marsano et al., Hydroxypropyl-cellulose derivatives: phase behaviour of hydroxypropylcellulose methacrylate, POLYMER, 41(2), 2000, pp. 533-538
Citation: C. Farina et S. Gagliardi, Selective inhibitors of the osteoclast vacuolar proton ATPase as novel bone antiresorptive agents, DRUG DISC T, 4(4), 1999, pp. 163-172
Citation: C. Farina et S. Gagliardi, Selective inhibitors of vacuolar H+-ATPase of osteoclasts with bone antiresorptive activity, EXPERT OP T, 9(2), 1999, pp. 157-168
Citation: S. Gagliardi et al., Chemistry and structure activity relationships of bafilomycin A(1), a potent and selective inhibitor of the vacuolar H+-ATPase, CURR MED CH, 6(12), 1999, pp. 1197-1212
Authors:
Atlante, A
Gagliardi, S
Marra, E
Calissano, P
Passarella, S
Citation: A. Atlante et al., Glutamate neurotoxicity in rat cerebellar granule cells involves cytochrome c release from mitochondria and mitochondrial shuttle impairment, J NEUROCHEM, 73(1), 1999, pp. 237-246
Authors:
Giardina, GAM
Artico, M
Cavagnera, S
Cerri, A
Consolandi, E
Gagliardi, S
Graziani, D
Grugni, M
Hay, DWP
Luttmann, MA
Mena, R
Raveglia, LF
Rigolio, R
Sarau, HM
Schmidt, DB
Zanoni, G
Farina, C
Citation: Gam. Giardina et al., Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonists, FARMACO, 54(6), 1999, pp. 364-374
Authors:
Nadler, G
Morvan, M
Delimoge, I
Belfiore, P
Zocchetti, A
James, I
Zembryki, D
Lee-Rycakzewski, E
Parini, C
Consolandi, E
Gagliardi, S
Farina, C
Citation: G. Nadler et al., (2Z,4E)-5-(5,6-dichloro-2-indolyl)-2-methoxy-N-(1,2,2,6,6-pentamethylpiperidin-4-yl)-2,4-pentadienamide, a novel, potent and selective inhibitor of the osteoclast V-ATPase, BIOORG MED, 8(24), 1998, pp. 3621-3626